Cellectar Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cellectar Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CLRB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001279704
Board of directors
-
Andrew Gu · DirectorSince 2026
-
Asher Chanan-Khan · DirectorSince 2023
-
Douglas J. Swirsky · DirectorSince 2023
-
Frederick W. Driscoll · DirectorSince 2023
-
James Caruso V · Director · President & CEOSince 2023
-
John Neis · DirectorSince 2023
-
Stefan Loren · DirectorSince 2023
Chief executives
James Caruso V
· President and CEO
Dates unknown
Director election results
Annual meeting of July 7, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.5%
-
98.8%
Board connections
1 of this board's directors also sit on 2 other boards.
- via Frederick W. Driscoll
- via Frederick W. Driscoll
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $49,997
- 2 purchases by 2 insiders
- Sold, last 12 months
- $733
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2026 | Longcor Jarrod Officer (Chief Operating Officer) | Open-market purchase | +8,680 | $2.88 | $24,998 |
| May 7, 2026 | James Caruso V Director, Officer (Chief Executive Officer) | Open-market purchase | +8,680 | $2.88 | $24,998 |
| Dec 12, 2025 | John Neis Director | Open-market sale | −198 | $3.70 | $733 |
| Jul 2, 2025 | James Caruso V Director, Officer (Chief Executive Officer) | Open-market purchase | +10,000 | $4.99 | $49,900 |
| Jul 2, 2025 | Longcor Jarrod Officer (Chief Operating Officer) | Open-market purchase | +10,000 | $4.99 | $49,900 |
| Jul 2, 2025 | Kolean Chad J Officer (Chief Financial Officer) | Open-market purchase | +5,000 | $4.99 | $24,950 |
| Jan 10, 2025 | Longcor Jarrod Officer (Chief Operating Officer) | Open-market purchase | +30,000 | $0.28 | $8,400 |
| Dec 8, 2023 | Lea Darrell Shane Officer (Chief Commercial Officer) | Grant or award | +39,599 | — | — |
| Dec 8, 2023 | Kolean Chad J Officer (Chief Financial Officer) | Grant or award | +42,554 | — | — |
| Dec 8, 2023 | Shustov Andrei Officer (Senior Vice President, Medical) | Grant or award | +47,856 | — | — |
| Dec 8, 2023 | Longcor Jarrod Officer (Chief Operating Officer) | Grant or award | +42,927 | — | — |
| Dec 8, 2023 | James Caruso V Director, Officer (President and CEO) | Grant or award | +40,596 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.